Nachrichten zur Eli Lilly & Co. Aktie

Has This Top Pharma Company Found Its Next Billion-Dollar Product?

Eli LIlly is looking to make waves in an important therapeutic area....…

ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration

read more...…

Eli Lilly sends ProQR 35% higher after expanding RNA editing deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lilly, ProQR To Expand Licensing And Collaboration Deal For New Genetic Medicines

INDIANAPOLIS (dpa-AFX) - Drug maker Eli Lilly and Co. (LLY) announced Thursday that it is expanding its licensing and collaboration…

Lilly and ProQR to Expand RNA Editing Collaboration

New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQRs Axiomer technology INDIANAPOLIS…

Eli Lilly (LLY) Stock Moves -0.58%: What You Should Know

In the latest trading session, Eli Lilly (LLY) closed at $357.78, marking a -0.58% move from the previous day....…

Herpes treatment market to grow by 4.05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth - Technavio

NEW YORK, Dec. 19, 2022 /PRNewswire/ -- Herpes treatment market insights - Vendors: 15+, including AbbVie Inc., AiCuris Anti infective…

Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop

WALTHAM, Mass., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a…

Time to Buy Eli Lilly (LLY) and AbbVie (ABBV) Stock for 2023?

AbbVies valuation, in particular, makes it a potentially strong candidate for 2023, while Eli Lillys growth could support its stock…

Eli Lilly diabetes drugs in shortage due to rising demand

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lilly, Sosei to develop new treatments for diabetes and metabolic diseases

Eli Lilly & Co. Inc. and Sosei Group Corp. said Friday they plan to develop and commercialize…

Jim Cramer gives his take on Eli Lilly

Cramer explained how investors should approach the stock....…

Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases

TOKYO and CAMBRIDGE, United Kingdom, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565)…

Jim Cramers Investing Club meeting Wednesday: Fed decision, Qualcomm, Eli Lilly

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET....…

Eli Lilly (LLY) 2023 Guidance Falls Short, Stock Declines

Eli Lillys (LLY) 2023 EPS guidance falls short of the Zacks Consensus Estimates and our model estimates. The company plans…

BRIEF-Lilly And Eva Pharma Announce Collaboration To Enhance Sustainable Access To Affordable Insulin In Africa

...Dec 14 (Reuters) - Eli Lilly and Co: * LILLY AND EVA PHARMA ANNOUNCE......…

Jim Cramers Investing Club meeting Tuesday: Inflation cools, stock trim, Eli Lilly

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET....…

UPDATE 2-Eli Lilly 2023 profit view disappoints on higher costs, strong dollar

...(Adds analyst comment, shares and more background) Dec 13 (Reuters......…

Eli Lilly forecasts 2023 adjusted profit below estimates

... estimate, not lower) (Reuters) -Eli Lilly and Co forecast 2023 adjusted......…

Eli Lilly Drops on Disappointing 2023 Earnings Outlook

Eli Lilly expects 2023 adjusted earnings to be in the range of $8.10 a share and $8.30 a share....…

Eli Lilly Issues FY23 Guidance; Reaffirms FY22 Outlook

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) stated that the company has potential to deliver top-tier, volume-driven revenue growth…

UPDATE 1-Eli Lilly forecasts 2023 adjusted profit below estimates

...(Adds details, background) Dec 13 (Reuters) - Eli Lilly and Co......…

Form 8-K ELI LILLY & Co For: Dec 13

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eli Lilly sets guidance for 2023 and stock falls as EPS lags current consensus

Eli Lilly & Co. announced guidance for 2023 on Tuesday and highlighted potential launches for a series of treatments,…

Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Eli Lilly (LLY) closed at $367.25, marking a +1.73% move from the previous day....…

Loxo@Lilly Presents Updated Pirtobrutinib Data from the Phase 1/2 BRUIN Clinical Trial at the 2022 American Society of Hematology Annual Meeting

Pirtobrutinib demonstrates activity across covalent BTK inhibitor pre-treated B-cell malignancies and multiple patient subgroups INDIANAPOLIS, Dec. 12, 2022 /PRNewswire/ --…

Eli Lilly raises dividend by 15% to $1.13

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lillys board OKs 15% dividend increase

Eli Lilly & Co. said Monday that its board has authorized a 15% increase in the pharma company's quarterly…

Eli Lilly & Co. Raises Dividend 15% to $1.13/Share

Eli Lilly & Co. Raises Dividend 15% to $1.13/Share...…

Eli Lilly: Kurszielerhöhung

IndianapolisZürich (www.aktiencheck.de) - Rating-Update: Colin Bristow, Analyst der UBS, stuft die Aktie des US-Pharmakonzerns Eli Lilly and Company (ISIN: US5324571083, WKN:…

Eli Lilly: Kursziel angehoben

San Francisco (www.aktiencheck.de) - Rating-Update: Mohit Bansal, Analyst von Wells Fargo Advisors, stuft die Aktie des US-Pharmakonzerns Eli Lilly and Company…

Wirtschaft: Ausstieg von Eli Lilly lässt Ypsomed-Aktien einbrechen +++ Behörden wollen Microsofts grösste Übernahme blockieren

Um den gesamten Artikel unter nzz.ch zu lesen, klicken Sie bitte auf die Überschrift...…

Herber Rückschlag für Ypsomed in den USA - Aktie schmiert ab

Medtech - Der für die geplante Markteinführung der Insulinpumpe «Ypsopump» in den USA gewonnene Partner Eli Lilly zieht sich vom…

Ypsomed muss für US-Lancierung der Insulinpumpe Ypsopump neuen Partner suchen

Herber Rückschlag für das Burgdorfer Medizinaltechnik-Unternehmen: Ypsomed: Eli Lilly zieht sich aus dem Projekt zurück....…

Ypsomed muss für US-Lancierung der Ypsopump neuen Partner suchen

Medtech - Herber Rückschlag für das Medizinaltechnikunternehmen Ypsomed: Der für die geplante Markteinführung der Insulinpumpe «Ypsopump» in den USA gewonnene…

Ypsomed muss für US-Lancierung der Ypsopump neuen Partner suchen

Herber Rückschlag für das Medizinaltechnikunternehmen Ypsomed: Der für die geplante Markteinführung der Insulinpumpe "Ypsopump" in den USA gewonnene Partner Eli…

Eli Lilly: Jardiance Improves Overall Blood Sugar Control In Children With Type 2 Diabetes

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) said the DINAMO phase III clinical trial met its primary endpoint by…

Eli Lilly sees “unprecedented” demand for its diabetes drugs

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

12 Analysts Have This to Say About Eli Lilly

Latest Ratings for LLY DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022MizuhoMaintainsBuy Jan 2022Morgan StanleyMaintainsOverweight View More…

Insiderhandel: Insider verkauft Aktien von Eli Lilly and Company im Wert von 18.304.193$

Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2022-12-02...…

Jim Cramers Investing Club meeting Monday: Trimming oil, Starbucks, Eli Lilly

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET....…

Insiderhandel: Insider verkauft Aktien von Eli Lilly and Company im Wert von 59.785.493$

Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2022-12-01...…

Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases

INDIANAPOLIS, Dec. 1, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition…

Eli Lilly COVID-19 therapy no longer authorized in U.S. - FDA

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

What increasing confidence in Biogens latest Alzheimers drug means for Eli Lilly

Eli Lillys (LLY) Alzheimers efforts are not central to our investment case, but Biogens (BIIB) full trial data is incrementally…

Lilly and Akouos Announce Expiration of Akouos Tender Offer

INDIANAPOLIS and BOSTON, Nov. 30, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today…

United States Pharmaceutical Industry Industry Report 2022 Featuring Abbot Laboratories, AbbVie, Allergan, Amgen, BMS, Eli Lilly and Co, Gilead Sciences, GSK, Johnson & Johnson, Merck, Pfizer, & Teva

DUBLIN, Nov. 29, 2022 /PRNewswire/ -- The "Pharmaceutical Industry in the United States 2022" report has been added to ResearchAndMarkets.coms…

Up 32% in 2022, Is Eli Lilly Stock Still a Buy?

In the market meltdown of 2022, this pharmaceutical stock bucked the trend and rose significantly....…

Eli Lilly Unusual Options Activity For November 23

Someone with a lot of money to spend has taken a bearish stance on Eli Lilly (NYSE:LLY). And retail traders should…

World Clinical Trials Racial Representation Data Study 2022 Featuring Novartis, GSK, Pfizer, Johnson & Johnson, AstraZeneca, F. Hoffmann-La Roche, Eli Lilly, Merck & Co, AbbVie, & Bayer

DUBLIN, Nov. 23, 2022 /PRNewswire/ -- The "Clinical Trials - The Importance of Diversity in Clinical Trials" report has been…